SEC Filings

Filing	Description	Date Filed	Size
5	graziano chane	Jan 27, 2012	25.4 KB
SC 13G/A	amended statement of beneficial ownership	Jan 19, 2012	34.3 KB
4	green, david	Jan 10, 2012	24.7 KB
4	luscinski, susan m	Jan 10, 2012	24.8 KB
10-Q	quarterly report	Nov 9, 2011	348.2 KB
8-K	current report	Nov 4, 2011	122.3 KB
10-Q	quarterly report	Aug 9, 2011	311.8 KB
8-K	current report	Aug 5, 2011	106.4 KB
4	luscinski, susan m	Jun 7, 2011	25.8 KB
4	mcnaughton, thomas	Jun 7, 2011	25.8 KB
4	green, david	Jun 7, 2011	25.7 KB
4	graziano, chane	Jun 7, 2011	25.7 KB
4	harte, neal j	Jun 7, 2011	24.3 KB
4	dishman, robert a	Jun 7, 2011	24.3 KB
4	kennedy, john f	Jun 7, 2011	24.4 KB
4	uveges, george	Jun 7, 2011	24.3 KB
4	lewis, earl r	Jun 7, 2011	24.4 KB
8-K	current report	May 27, 2011	32.8 KB
S-8	registration statement	May 25, 2011	55.0 KB
10-Q	quarterly report	May 6, 2011	258.9 KB
Showing 1-20 of 462 Page: 1 2 3 ... 24  Next 20

Disclaimer:
The information contained within this and other Harvard Bioscience Web pages should be deemed accurate and current as of the date of the most recent update, or if no update information has been provided, the date of issuance. Harvard Bioscience assumes no responsibility for any misincurrances or misstatements which occur as the result of the reading of dated material. Users are strongly encouraged to check dates of issuance and most recent update of any information contained within, or linked to, Harvard Bioscience’s web site. For Harvard Bioscience’s most current information please reference Harvard Bioscience public filings with the Securities and Exchange Commission located at http://www.sec.gov.